Pfizer Vaccine By October

Pfizer which has partnered with biontech on its coronavirus vaccine has begun enrolling 30 000 people in its phase three vaccine trial but is looking to expand its enrollment to 44 000.

Pfizer vaccine by october. Pfizer alone has a budget of 2 billion for a vaccine and antiviral drugs with the lion s share to be spent on the vaccine. And spending will be frontloaded that is we must initially spend at least 1 billion this year. Covid 19 vaccine could arrive in october by carolyn crist may 14 2020 pharmaceutical company pfizer plans to expand human clinical trials for a coronavirus vaccine and include thousands. In a recent interview moderna s chief executive stéphane bancel said.

By katie thomas in media appearances and talks with investors pfizer s chief. Pfizer which had previously said that it could have vaccine efficacy data in october expressed hope it could supply some 40 million doses in the united states this year if clinical testing proceeds as expected and regulators approve its single nucleoside modified messenger rna modrna vaccine. And biontech se said the covid 19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as october as they released additional data from an. Pfizer ceo albert bourla had previously said the company may know whether or not our vaccine is effective by the end of october more.

October is possible because very few things in life are impossible. Pfizer says it may know whether its vaccine works by the end of october and that it could be ready to apply for emergency use authorization of its covid 19 vaccine by late november. Mid november earliest it can seek virus vaccine ok. Pfizer s leading competitors in the vaccine race moderna and astrazeneca have been more vague about timing saying they expect something before the end of the year.